Skip to content
The Morning Dispatch: How Worrisome Is the New COVID Variant?

The Morning Dispatch: How Worrisome Is the New COVID Variant?

Plus: A Chinese journalist faces a four-year sentence for her reporting from the early days of the pandemic.
The Dispatch Staff /
The Morning Dispatch: How Worrisome Is the New COVID Variant?

Happy Tuesday! The Chicago Cubs made a very bad trade last night, and one of your Morning Dispatchers is very angry about it. (Editor’s note: The St. Louis Cardinals and Milwaukee Brewers fans on staff, however, are thrilled.)

Quick Hits: Today’s Top Stories

  • The House of Representatives voted 275-134 on Monday to boost the size of the stimulus checks in the recently passed coronavirus relief package from $600 per person to $2,000 per person. President Trump has repeatedly voiced his support for the measure, but it was mostly Democrats (alongside a few dozen Republicans) who voted to approve it. The measure now heads to the Republican-held Senate, where it is unlikely to pass—if it is even brought up for a vote at all. Replacing $600 checks with $2,000 checks would cost about $464 billion, according to the nonpartisan Joint Committee on Taxation.

  • The House voted 322-87 to override President Trump’s veto of the $740 billion National Defense Authorization Act (NDAA), which funds various national security priorities—including the military. The Senate will vote on whether to override the veto as early as today. Sen. Bernie Sanders said Monday he plans to filibuster the vote until Senate Majority Leader Mitch McConnell brings the $2,000-per-person checks up for a vote. 

  • Nearly 1.3 million people were screened at U.S. airport checkpoints on Sunday, according to data from the Transportation Security Administration. Although the figure is just about half the nearly 2.6 million who flew on the same day last year, it represents the highest single-day tally since the onset of the pandemic in March.

  • The Novavax COVID-19 vaccine on Monday became the fifth to begin late-stage clinical trials in the U.S., with the company announcing it will enroll up to 30,000 people in the U.S. and Mexico to test the safety and efficacy of its vaccine candidate. If the trials are successful, the vaccine could receive emergency use authorization at some point in the spring.

  • The United States confirmed 170,592 new cases of COVID-19 yesterday per the Johns Hopkins University COVID-19 Dashboard, with 10.8 percent of the 1,584,360 tests reported coming back positive. An additional 1,720 deaths were attributed to the virus on Monday, bringing the pandemic’s American death toll to 334,830. According to the COVID Tracking Project, 121,235 Americans are currently hospitalized with COVID-19. According to the Centers for Disease Control, 11,445,175 COVID-19 vaccine doses have been distributed nationwide, and 2,127,143 have been administered.

About That New COVID-19 Mutation ...

We wrote last week about the new—and apparently more infectious—variant of the coronavirus that is causing serious concern across Europe, with parts of Britain returning to hardcore lockdown and many countries limiting travel from the U.K. Over the weekend, the United States got in on the action too, implementing a new rule requiring would-be air travelers from Britain to first clear a COVID test before their departure.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Newsletter selected

Click sign up to start receiving your newsletters.

More We Think You’d Like

Newsletter selected

Click sign up to start receiving your newsletters.

Loading